Envestnet Asset Management’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$794K Buy
18,953
+9,565
+102% +$370K ﹤0.01% 3762
2026
Q1
$354K Buy
+9,388
New +$307K ﹤0.01% 4179
2025
Q4
Sell
-9,220
Closed -$242K 4707
2025
Q3
$242K Sell
9,220
-2,906
-24% -$69.3K ﹤0.01% 4211
2025
Q2
$258K Buy
12,126
+805
+7% +$18.2K ﹤0.01% 4101
2025
Q1
$241K Sell
11,321
-689
-6% -$14.1K ﹤0.01% 4048
2024
Q4
$243K Buy
12,010
+564
+5% +$11.6K ﹤0.01% 3996
2024
Q3
$192K Buy
+11,446
New +$193K ﹤0.01% 4025

Other funds holding GRDN

Envestnet Asset Management's GRDN Position: Q2 2026 in Review

Envestnet Asset Management increased its Guardian Pharmacy Services (GRDN) stake by 102% in Q2 2026, buying an estimated $370K and bringing the position to 18,953 shares worth $794K. The position accounts for ﹤0.01% of the portfolio, ranked #3762.

Envestnet Asset Management first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Envestnet Asset Management held 18,953 shares of Guardian Pharmacy Services worth $794K as of Q2 2026.
  • Envestnet Asset Management bought 9,565 Guardian Pharmacy Services shares in Q2 2026, an estimated $370K.
  • Guardian Pharmacy Services made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3762 holding.
  • Envestnet Asset Management first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.